

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | axonemal dynein complex assembly (GO:0070286) | 9.05895937 |
| 2 | daunorubicin metabolic process (GO:0044597) | 8.40406914 |
| 3 | polyketide metabolic process (GO:0030638) | 8.40406914 |
| 4 | doxorubicin metabolic process (GO:0044598) | 8.40406914 |
| 5 | aminoglycoside antibiotic metabolic process (GO:0030647) | 7.42111572 |
| 6 | primary alcohol catabolic process (GO:0034310) | 7.20687404 |
| 7 | cilium or flagellum-dependent cell motility (GO:0001539) | 7.10612185 |
| 8 | cilium movement (GO:0003341) | 6.88412668 |
| 9 | epithelial cilium movement (GO:0003351) | 6.28522533 |
| 10 | motile cilium assembly (GO:0044458) | 5.85048875 |
| 11 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 5.42375990 |
| 12 | cellular glucuronidation (GO:0052695) | 5.27735548 |
| 13 | glycoside metabolic process (GO:0016137) | 5.21154971 |
| 14 | glucuronate metabolic process (GO:0019585) | 5.11613491 |
| 15 | uronic acid metabolic process (GO:0006063) | 5.11613491 |
| 16 | ethanol oxidation (GO:0006069) | 4.71922521 |
| 17 | ethanol metabolic process (GO:0006067) | 4.66445767 |
| 18 | intestinal cholesterol absorption (GO:0030299) | 4.50247849 |
| 19 | L-ascorbic acid metabolic process (GO:0019852) | 4.43500574 |
| 20 | progesterone metabolic process (GO:0042448) | 4.37467662 |
| 21 | fibrinolysis (GO:0042730) | 4.23284755 |
| 22 | regulation of bile acid biosynthetic process (GO:0070857) | 4.22511517 |
| 23 | regulation of triglyceride catabolic process (GO:0010896) | 4.21943740 |
| 24 | exogenous drug catabolic process (GO:0042738) | 4.19950215 |
| 25 | drug catabolic process (GO:0042737) | 4.15299723 |
| 26 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.11910597 |
| 27 | L-phenylalanine metabolic process (GO:0006558) | 4.11910597 |
| 28 | negative regulation of fibrinolysis (GO:0051918) | 4.07396474 |
| 29 | diterpenoid biosynthetic process (GO:0016102) | 4.05892422 |
| 30 | retinal metabolic process (GO:0042574) | 3.99778840 |
| 31 | epoxygenase P450 pathway (GO:0019373) | 3.98332452 |
| 32 | digestion (GO:0007586) | 3.88698057 |
| 33 | primary alcohol metabolic process (GO:0034308) | 3.82050690 |
| 34 | bile acid metabolic process (GO:0008206) | 3.81392743 |
| 35 | bile acid and bile salt transport (GO:0015721) | 3.80600084 |
| 36 | hormone catabolic process (GO:0042447) | 3.78324044 |
| 37 | urea metabolic process (GO:0019627) | 3.74717735 |
| 38 | vitamin transmembrane transport (GO:0035461) | 3.71303491 |
| 39 | regulation of fibrinolysis (GO:0051917) | 3.67765413 |
| 40 | intestinal absorption (GO:0050892) | 3.66947991 |
| 41 | negative regulation of coagulation (GO:0050819) | 3.60355918 |
| 42 | regulation of protein activation cascade (GO:2000257) | 3.58312110 |
| 43 | regulation of metalloenzyme activity (GO:0048552) | 3.54829235 |
| 44 | negative regulation of blood coagulation (GO:0030195) | 3.53635648 |
| 45 | negative regulation of hemostasis (GO:1900047) | 3.53635648 |
| 46 | quinone metabolic process (GO:1901661) | 3.53599369 |
| 47 | flavonoid metabolic process (GO:0009812) | 3.50690024 |
| 48 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.50508267 |
| 49 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.50508267 |
| 50 | cobalamin metabolic process (GO:0009235) | 3.50206771 |
| 51 | urea cycle (GO:0000050) | 3.47326750 |
| 52 | regulation of complement activation (GO:0030449) | 3.44382086 |
| 53 | drug metabolic process (GO:0017144) | 3.37744423 |
| 54 | androgen biosynthetic process (GO:0006702) | 3.37177293 |
| 55 | negative regulation of wound healing (GO:0061045) | 3.34664730 |
| 56 | nitrogen cycle metabolic process (GO:0071941) | 3.32682917 |
| 57 | left/right pattern formation (GO:0060972) | 3.32535217 |
| 58 | cell adhesion mediated by integrin (GO:0033627) | 3.31701906 |
| 59 | artery smooth muscle contraction (GO:0014824) | 3.29947098 |
| 60 | drug transmembrane transport (GO:0006855) | 3.29803521 |
| 61 | glutathione derivative metabolic process (GO:1901685) | 3.28852669 |
| 62 | glutathione derivative biosynthetic process (GO:1901687) | 3.28852669 |
| 63 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.18048985 |
| 64 | L-phenylalanine catabolic process (GO:0006559) | 3.18048985 |
| 65 | bile acid biosynthetic process (GO:0006699) | 3.15021342 |
| 66 | transcytosis (GO:0045056) | 3.14561916 |
| 67 | cellular aldehyde metabolic process (GO:0006081) | 3.13590319 |
| 68 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.12152535 |
| 69 | protein carboxylation (GO:0018214) | 3.12152535 |
| 70 | androgen metabolic process (GO:0008209) | 3.08433352 |
| 71 | renal absorption (GO:0070293) | 3.07076014 |
| 72 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.04066277 |
| 73 | regulation of plasminogen activation (GO:0010755) | 3.02796527 |
| 74 | C21-steroid hormone metabolic process (GO:0008207) | 3.01726590 |
| 75 | cyclooxygenase pathway (GO:0019371) | 3.00016922 |
| 76 | negative regulation of humoral immune response (GO:0002921) | 2.99509597 |
| 77 | phenylpropanoid metabolic process (GO:0009698) | 2.98862602 |
| 78 | xenobiotic metabolic process (GO:0006805) | 2.98318259 |
| 79 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.89936341 |
| 80 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.88924731 |
| 81 | axoneme assembly (GO:0035082) | 2.88856602 |
| 82 | omega-hydroxylase P450 pathway (GO:0097267) | 2.88300507 |
| 83 | gap junction assembly (GO:0016264) | 2.86058274 |
| 84 | negative regulation of protein activation cascade (GO:2000258) | 2.85334072 |
| 85 | tonic smooth muscle contraction (GO:0014820) | 2.79271996 |
| 86 | hepatocyte differentiation (GO:0070365) | 2.77909075 |
| 87 | desmosome organization (GO:0002934) | 2.77751094 |
| 88 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.77366607 |
| 89 | terpenoid biosynthetic process (GO:0016114) | 2.76905878 |
| 90 | endothelial cell morphogenesis (GO:0001886) | 2.75297338 |
| 91 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.74352387 |
| 92 | retinol metabolic process (GO:0042572) | 2.74133921 |
| 93 | glycolipid catabolic process (GO:0019377) | 2.73223680 |
| 94 | negative regulation of complement activation (GO:0045916) | 2.70684950 |
| 95 | ventricular system development (GO:0021591) | 2.69183426 |
| 96 | prostaglandin metabolic process (GO:0006693) | 2.69005199 |
| 97 | prostanoid metabolic process (GO:0006692) | 2.69005199 |
| 98 | intraciliary transport (GO:0042073) | 2.67774393 |
| 99 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.64678943 |
| 100 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.62870911 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.88091609 |
| 2 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 4.70709582 |
| 3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.18218038 |
| 4 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 4.13978977 |
| 5 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 3.75315864 |
| 6 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.97260529 |
| 7 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.96097124 |
| 8 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.93326983 |
| 9 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.87754086 |
| 10 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.78191887 |
| 11 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.70995930 |
| 12 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 2.62643643 |
| 13 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 2.61430436 |
| 14 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.56707395 |
| 15 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.53203777 |
| 16 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.46582177 |
| 17 | GATA4_25053715_ChIP-Seq_YYC3_Human | 2.43885251 |
| 18 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.41282028 |
| 19 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.36306082 |
| 20 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.36262803 |
| 21 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.34698296 |
| 22 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.21823899 |
| 23 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 2.10182621 |
| 24 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.09905955 |
| 25 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.08917671 |
| 26 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.00706661 |
| 27 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.92827563 |
| 28 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.92827563 |
| 29 | CJUN_26792858_Chip-Seq_BT549_Human | 1.92328051 |
| 30 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.92247269 |
| 31 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.85663402 |
| 32 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.81464932 |
| 33 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.77892744 |
| 34 | VDR_22108803_ChIP-Seq_LS180_Human | 1.73024483 |
| 35 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.72253911 |
| 36 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.69547980 |
| 37 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.63617981 |
| 38 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.62314414 |
| 39 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.60114935 |
| 40 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.58760313 |
| 41 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.57920690 |
| 42 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.57643110 |
| 43 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.54600059 |
| 44 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.52910307 |
| 45 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.52007679 |
| 46 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.49574012 |
| 47 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.49190693 |
| 48 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.46761232 |
| 49 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.45436293 |
| 50 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.45143444 |
| 51 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.45132364 |
| 52 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.44679908 |
| 53 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.40484933 |
| 54 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.40332054 |
| 55 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.39022373 |
| 56 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.37161152 |
| 57 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.34283148 |
| 58 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.28512990 |
| 59 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.27703828 |
| 60 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.27703828 |
| 61 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.26895924 |
| 62 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.23958108 |
| 63 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.22185255 |
| 64 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.20618416 |
| 65 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.19822045 |
| 66 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.15825905 |
| 67 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.14765581 |
| 68 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.14397329 |
| 69 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.13697529 |
| 70 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.13452847 |
| 71 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.13334163 |
| 72 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.10797099 |
| 73 | ATF3_27146783_Chip-Seq_COLON_Human | 1.10429488 |
| 74 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.08954749 |
| 75 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.06577457 |
| 76 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.06503552 |
| 77 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.05384056 |
| 78 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.05111854 |
| 79 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.03396957 |
| 80 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.02536813 |
| 81 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.99688208 |
| 82 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.98863391 |
| 83 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.96993151 |
| 84 | CBP_21632823_ChIP-Seq_H3396_Human | 0.93673268 |
| 85 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.92149622 |
| 86 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.91094414 |
| 87 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.89347806 |
| 88 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.88965151 |
| 89 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.88914563 |
| 90 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.85717789 |
| 91 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.83306732 |
| 92 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.82726118 |
| 93 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.82690383 |
| 94 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.82532820 |
| 95 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.78648547 |
| 96 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.77882616 |
| 97 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.73981454 |
| 98 | AR_20517297_ChIP-Seq_VCAP_Human | 0.73544293 |
| 99 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.70338284 |
| 100 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.68587952 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.61397062 |
| 2 | MP0005360_urolithiasis | 5.33816861 |
| 3 | MP0005365_abnormal_bile_salt | 5.16185201 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.71799480 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.48339798 |
| 6 | MP0001666_abnormal_nutrient_absorption | 4.46352643 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.98683087 |
| 8 | MP0003868_abnormal_feces_composition | 3.26725307 |
| 9 | MP0010368_abnormal_lymphatic_system | 3.09094242 |
| 10 | MP0004019_abnormal_vitamin_homeostasis | 3.01021632 |
| 11 | MP0003252_abnormal_bile_duct | 2.83625428 |
| 12 | MP0002138_abnormal_hepatobiliary_system | 2.74940380 |
| 13 | MP0005408_hypopigmentation | 2.10229869 |
| 14 | MP0004272_abnormal_basement_membrane | 2.08932803 |
| 15 | MP0001879_abnormal_lymphatic_vessel | 2.02723487 |
| 16 | MP0009697_abnormal_copulation | 1.99720470 |
| 17 | MP0010329_abnormal_lipoprotein_level | 1.84940421 |
| 18 | MP0005409_darkened_coat_color | 1.75071686 |
| 19 | MP0003191_abnormal_cellular_cholesterol | 1.71559232 |
| 20 | MP0000537_abnormal_urethra_morphology | 1.53786403 |
| 21 | MP0005164_abnormal_response_to | 1.52171122 |
| 22 | MP0010234_abnormal_vibrissa_follicle | 1.48365952 |
| 23 | MP0005623_abnormal_meninges_morphology | 1.46759817 |
| 24 | MP0003566_abnormal_cell_adhesion | 1.43745624 |
| 25 | MP0004264_abnormal_extraembryonic_tissu | 1.40766018 |
| 26 | MP0005332_abnormal_amino_acid | 1.39306239 |
| 27 | MP0009643_abnormal_urine_homeostasis | 1.38955240 |
| 28 | MP0009780_abnormal_chondrocyte_physiolo | 1.38061163 |
| 29 | MP0009840_abnormal_foam_cell | 1.36795453 |
| 30 | MP0000609_abnormal_liver_physiology | 1.29079843 |
| 31 | MP0003950_abnormal_plasma_membrane | 1.26482383 |
| 32 | MP0003195_calcinosis | 1.22240838 |
| 33 | MP0010352_gastrointestinal_tract_polyps | 1.19717257 |
| 34 | MP0002118_abnormal_lipid_homeostasis | 1.14911500 |
| 35 | MP0005636_abnormal_mineral_homeostasis | 1.14454172 |
| 36 | MP0005165_increased_susceptibility_to | 1.13710436 |
| 37 | MP0000465_gastrointestinal_hemorrhage | 1.11875590 |
| 38 | MP0001764_abnormal_homeostasis | 1.10748773 |
| 39 | MP0002132_abnormal_respiratory_system | 1.08453418 |
| 40 | MP0003718_maternal_effect | 1.06296126 |
| 41 | MP0004883_abnormal_blood_vessel | 1.03989049 |
| 42 | MP0010386_abnormal_urinary_bladder | 0.98624016 |
| 43 | MP0000249_abnormal_blood_vessel | 0.96626143 |
| 44 | MP0005376_homeostasis/metabolism_phenot | 0.96385141 |
| 45 | MP0009053_abnormal_anal_canal | 0.94989768 |
| 46 | MP0002877_abnormal_melanocyte_morpholog | 0.93532397 |
| 47 | MP0000566_synostosis | 0.91906080 |
| 48 | MP0005023_abnormal_wound_healing | 0.91105116 |
| 49 | MP0003828_pulmonary_edema | 0.89569055 |
| 50 | MP0005395_other_phenotype | 0.89067324 |
| 51 | MP0010155_abnormal_intestine_physiology | 0.88159791 |
| 52 | MP0002796_impaired_skin_barrier | 0.87859987 |
| 53 | MP0003943_abnormal_hepatobiliary_system | 0.86634588 |
| 54 | MP0006054_spinal_hemorrhage | 0.86391106 |
| 55 | MP0002136_abnormal_kidney_physiology | 0.85964493 |
| 56 | MP0005167_abnormal_blood-brain_barrier | 0.84323699 |
| 57 | MP0006138_congestive_heart_failure | 0.83263248 |
| 58 | MP0001765_abnormal_ion_homeostasis | 0.79516033 |
| 59 | MP0010678_abnormal_skin_adnexa | 0.79447986 |
| 60 | MP0004043_abnormal_pH_regulation | 0.79123926 |
| 61 | MP0005501_abnormal_skin_physiology | 0.78122661 |
| 62 | MP0005319_abnormal_enzyme/_coenzyme | 0.77676141 |
| 63 | MP0000858_altered_metastatic_potential | 0.77244057 |
| 64 | MP0003453_abnormal_keratinocyte_physiol | 0.74408749 |
| 65 | MP0000762_abnormal_tongue_morphology | 0.73322944 |
| 66 | MP0001915_intracranial_hemorrhage | 0.73310707 |
| 67 | MP0005187_abnormal_penis_morphology | 0.72583867 |
| 68 | MP0002282_abnormal_trachea_morphology | 0.72498604 |
| 69 | MP0004782_abnormal_surfactant_physiolog | 0.71504922 |
| 70 | MP0000467_abnormal_esophagus_morphology | 0.71303317 |
| 71 | MP0010030_abnormal_orbit_morphology | 0.70749772 |
| 72 | MP0003186_abnormal_redox_activity | 0.69849438 |
| 73 | MP0000598_abnormal_liver_morphology | 0.69148421 |
| 74 | MP0002876_abnormal_thyroid_physiology | 0.68909273 |
| 75 | MP0003705_abnormal_hypodermis_morpholog | 0.68161964 |
| 76 | MP0005330_cardiomyopathy | 0.66257590 |
| 77 | MP0005083_abnormal_biliary_tract | 0.65673608 |
| 78 | MP0003091_abnormal_cell_migration | 0.65004047 |
| 79 | MP0008873_increased_physiological_sensi | 0.64706206 |
| 80 | MP0008260_abnormal_autophagy | 0.63633672 |
| 81 | MP0009765_abnormal_xenobiotic_induced | 0.61768738 |
| 82 | MP0002168_other_aberrant_phenotype | 0.61089523 |
| 83 | MP0000013_abnormal_adipose_tissue | 0.60644123 |
| 84 | MP0000383_abnormal_hair_follicle | 0.60542750 |
| 85 | MP0005166_decreased_susceptibility_to | 0.58798773 |
| 86 | MP0003656_abnormal_erythrocyte_physiolo | 0.58676426 |
| 87 | MP0002896_abnormal_bone_mineralization | 0.57305480 |
| 88 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.55258598 |
| 89 | MP0000490_abnormal_crypts_of | 0.54490975 |
| 90 | MP0009763_increased_sensitivity_to | 0.53452477 |
| 91 | MP0001756_abnormal_urination | 0.53101105 |
| 92 | MP0009642_abnormal_blood_homeostasis | 0.53086112 |
| 93 | MP0003959_abnormal_lean_body | 0.52994762 |
| 94 | MP0005670_abnormal_white_adipose | 0.48693735 |
| 95 | MP0001664_abnormal_digestion | 0.47875420 |
| 96 | MP0000477_abnormal_intestine_morphology | 0.46352670 |
| 97 | MP0002098_abnormal_vibrissa_morphology | 0.46189462 |
| 98 | MP0000767_abnormal_smooth_muscle | 0.45973598 |
| 99 | MP0006036_abnormal_mitochondrial_physio | 0.45410039 |
| 100 | MP0008004_abnormal_stomach_pH | 0.45273299 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 9.17125949 |
| 2 | Abnormal respiratory motile cilium physiology (HP:0012261) | 8.37670288 |
| 3 | Abnormal ciliary motility (HP:0012262) | 7.96470199 |
| 4 | Absent/shortened dynein arms (HP:0200106) | 7.62014580 |
| 5 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 7.62014580 |
| 6 | Abnormal respiratory motile cilium morphology (HP:0005938) | 7.60361780 |
| 7 | Abnormal respiratory epithelium morphology (HP:0012253) | 7.60361780 |
| 8 | Rhinitis (HP:0012384) | 7.51786437 |
| 9 | Chronic bronchitis (HP:0004469) | 6.09629694 |
| 10 | Bronchiectasis (HP:0002110) | 5.05949590 |
| 11 | Abnormality of the nasal mucosa (HP:0000433) | 4.54962691 |
| 12 | Nasal polyposis (HP:0100582) | 4.40799551 |
| 13 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.33874007 |
| 14 | Deep venous thrombosis (HP:0002625) | 4.26464850 |
| 15 | Hypobetalipoproteinemia (HP:0003563) | 4.16480976 |
| 16 | Fat malabsorption (HP:0002630) | 4.14399660 |
| 17 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.97693638 |
| 18 | Steatorrhea (HP:0002570) | 3.91913625 |
| 19 | Conjugated hyperbilirubinemia (HP:0002908) | 3.69108041 |
| 20 | Vascular calcification (HP:0004934) | 3.51585006 |
| 21 | Abnormality of proline metabolism (HP:0010907) | 3.16984970 |
| 22 | Hydroxyprolinuria (HP:0003080) | 3.16984970 |
| 23 | Cardiovascular calcification (HP:0011915) | 3.08779943 |
| 24 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.08477739 |
| 25 | Bronchitis (HP:0012387) | 3.05205445 |
| 26 | Infertility (HP:0000789) | 3.04925386 |
| 27 | Prolonged partial thromboplastin time (HP:0003645) | 3.04255727 |
| 28 | Chronic sinusitis (HP:0011109) | 3.03056786 |
| 29 | Short nail (HP:0001799) | 2.83675603 |
| 30 | Male infertility (HP:0003251) | 2.81677839 |
| 31 | Tetraparesis (HP:0002273) | 2.79952674 |
| 32 | Occipital encephalocele (HP:0002085) | 2.72080716 |
| 33 | Hyperactive renin-angiotensin system (HP:0000841) | 2.55143290 |
| 34 | Recurrent otitis media (HP:0000403) | 2.53376126 |
| 35 | Flat acetabular roof (HP:0003180) | 2.40712132 |
| 36 | Complement deficiency (HP:0004431) | 2.33157980 |
| 37 | Confusion (HP:0001289) | 2.24852050 |
| 38 | Hypolipoproteinemia (HP:0010981) | 2.18789336 |
| 39 | Abnormality of the common coagulation pathway (HP:0010990) | 2.13706364 |
| 40 | Recurrent sinusitis (HP:0011108) | 2.11388968 |
| 41 | Intrahepatic cholestasis (HP:0001406) | 2.08372179 |
| 42 | Abnormality of the hepatic vasculature (HP:0006707) | 2.07645440 |
| 43 | Arterial tortuosity (HP:0005116) | 2.05670376 |
| 44 | True hermaphroditism (HP:0010459) | 2.05502091 |
| 45 | Atelectasis (HP:0100750) | 2.05298067 |
| 46 | Joint hemorrhage (HP:0005261) | 2.03898495 |
| 47 | Vascular tortuosity (HP:0004948) | 2.02367632 |
| 48 | Focal segmental glomerulosclerosis (HP:0000097) | 1.98832254 |
| 49 | Malnutrition (HP:0004395) | 1.97642709 |
| 50 | Abnormality of complement system (HP:0005339) | 1.96685049 |
| 51 | Abnormality of the intrinsic pathway (HP:0010989) | 1.94206865 |
| 52 | Glucose intolerance (HP:0000833) | 1.93277876 |
| 53 | Hemorrhage of the eye (HP:0011885) | 1.91509726 |
| 54 | Abnormality of carpal bone ossification (HP:0006257) | 1.88048799 |
| 55 | Xanthomatosis (HP:0000991) | 1.86803777 |
| 56 | Tubulointerstitial nephritis (HP:0001970) | 1.85398571 |
| 57 | Esophageal varix (HP:0002040) | 1.84750853 |
| 58 | Portal hypertension (HP:0001409) | 1.84118016 |
| 59 | Hyperammonemia (HP:0001987) | 1.80159072 |
| 60 | Reduced antithrombin III activity (HP:0001976) | 1.77808021 |
| 61 | Abnormality of vitamin metabolism (HP:0100508) | 1.76434258 |
| 62 | Mitral stenosis (HP:0001718) | 1.73950167 |
| 63 | Glomerulosclerosis (HP:0000096) | 1.71662112 |
| 64 | Tubular atrophy (HP:0000092) | 1.71407548 |
| 65 | Pancreatic fibrosis (HP:0100732) | 1.69625760 |
| 66 | Cystic liver disease (HP:0006706) | 1.66771721 |
| 67 | Menorrhagia (HP:0000132) | 1.65934361 |
| 68 | Ankyloglossia (HP:0010296) | 1.64073895 |
| 69 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.63716030 |
| 70 | Glomerulonephritis (HP:0000099) | 1.61103965 |
| 71 | Pigmentary retinal degeneration (HP:0001146) | 1.60327475 |
| 72 | Abnormal glucose tolerance (HP:0001952) | 1.60022936 |
| 73 | Hypercholesterolemia (HP:0003124) | 1.58464155 |
| 74 | Rickets (HP:0002748) | 1.57287909 |
| 75 | Glycosuria (HP:0003076) | 1.56020163 |
| 76 | Abnormality of urine glucose concentration (HP:0011016) | 1.56020163 |
| 77 | Acanthocytosis (HP:0001927) | 1.54991049 |
| 78 | Cone-rod dystrophy (HP:0000548) | 1.54732021 |
| 79 | Abnormality of dentin (HP:0010299) | 1.53006251 |
| 80 | Abnormality of the dental root (HP:0006486) | 1.52297306 |
| 81 | Taurodontia (HP:0000679) | 1.52297306 |
| 82 | Abnormality of permanent molar morphology (HP:0011071) | 1.52297306 |
| 83 | Generalized aminoaciduria (HP:0002909) | 1.51573681 |
| 84 | Male pseudohermaphroditism (HP:0000037) | 1.50754723 |
| 85 | Hepatocellular carcinoma (HP:0001402) | 1.50673512 |
| 86 | Exocrine pancreatic insufficiency (HP:0001738) | 1.50572965 |
| 87 | Congenital hepatic fibrosis (HP:0002612) | 1.50354087 |
| 88 | Abnormality of oral frenula (HP:0000190) | 1.48927245 |
| 89 | Systemic lupus erythematosus (HP:0002725) | 1.48608104 |
| 90 | Proximal tubulopathy (HP:0000114) | 1.45053361 |
| 91 | Chronic hepatic failure (HP:0100626) | 1.43876195 |
| 92 | Nephritis (HP:0000123) | 1.43073309 |
| 93 | Hypotension (HP:0002615) | 1.42184044 |
| 94 | Chronic otitis media (HP:0000389) | 1.41412977 |
| 95 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.40707872 |
| 96 | Hyponatremia (HP:0002902) | 1.39290731 |
| 97 | Abnormality of the Achilles tendon (HP:0005109) | 1.38335544 |
| 98 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.37789643 |
| 99 | Osteolytic defects of the hand bones (HP:0009699) | 1.37789643 |
| 100 | Abnormality of nucleobase metabolism (HP:0010932) | 1.36390487 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MST1R | 6.77555231 |
| 2 | EPHA2 | 5.12886622 |
| 3 | MST4 | 4.33769560 |
| 4 | EPHB2 | 3.88003156 |
| 5 | MAPK15 | 3.85669430 |
| 6 | MET | 3.42115114 |
| 7 | EIF2AK1 | 2.67229162 |
| 8 | TIE1 | 2.49360140 |
| 9 | SCYL2 | 2.40399978 |
| 10 | STK39 | 2.37877200 |
| 11 | IRAK3 | 2.26695476 |
| 12 | MAP3K12 | 2.12450331 |
| 13 | PDK2 | 1.98616018 |
| 14 | ACVR1B | 1.69711264 |
| 15 | ERBB3 | 1.66817327 |
| 16 | TESK1 | 1.63998429 |
| 17 | MAPKAPK3 | 1.61685611 |
| 18 | EIF2AK3 | 1.51766408 |
| 19 | NME1 | 1.51042220 |
| 20 | TRPM7 | 1.50161281 |
| 21 | CCNB1 | 1.45139074 |
| 22 | NME2 | 1.42073106 |
| 23 | MAP3K2 | 1.41294667 |
| 24 | ERBB4 | 1.41163863 |
| 25 | PTK2B | 1.38608120 |
| 26 | ERN1 | 1.31879605 |
| 27 | PTK2 | 1.28165350 |
| 28 | NEK9 | 1.23642772 |
| 29 | OXSR1 | 1.20540838 |
| 30 | CDK8 | 1.13485474 |
| 31 | TGFBR2 | 1.12514089 |
| 32 | MAP3K3 | 1.12342543 |
| 33 | PAK4 | 1.11213031 |
| 34 | LIMK1 | 1.05623258 |
| 35 | LMTK2 | 1.01029330 |
| 36 | PNCK | 1.00463128 |
| 37 | BMX | 0.92355311 |
| 38 | BCR | 0.86121256 |
| 39 | STK10 | 0.85305628 |
| 40 | FER | 0.85285230 |
| 41 | PBK | 0.84487082 |
| 42 | LRRK2 | 0.82692730 |
| 43 | PRKG2 | 0.82413818 |
| 44 | NEK6 | 0.81587423 |
| 45 | TSSK6 | 0.78313891 |
| 46 | TBK1 | 0.77168465 |
| 47 | RPS6KB2 | 0.74799919 |
| 48 | FRK | 0.73429481 |
| 49 | WNK4 | 0.73294053 |
| 50 | RIPK1 | 0.71841058 |
| 51 | EPHB1 | 0.71427812 |
| 52 | STK16 | 0.70646562 |
| 53 | MYLK | 0.68346003 |
| 54 | FGFR4 | 0.64063168 |
| 55 | ICK | 0.59477158 |
| 56 | STK38 | 0.59283521 |
| 57 | PIK3CA | 0.59110843 |
| 58 | STK24 | 0.58834775 |
| 59 | TTN | 0.57214510 |
| 60 | EPHA3 | 0.54847980 |
| 61 | TEC | 0.54785401 |
| 62 | MELK | 0.51445435 |
| 63 | STK38L | 0.49882423 |
| 64 | LATS1 | 0.49497331 |
| 65 | BMPR1B | 0.48559375 |
| 66 | NEK1 | 0.48439153 |
| 67 | CAMK2G | 0.47284998 |
| 68 | IGF1R | 0.46085423 |
| 69 | GRK1 | 0.44081641 |
| 70 | MAPKAPK5 | 0.43467816 |
| 71 | KDR | 0.42676960 |
| 72 | FGFR1 | 0.42358569 |
| 73 | MAP3K7 | 0.39753111 |
| 74 | ABL2 | 0.38481458 |
| 75 | PRKD3 | 0.37757492 |
| 76 | PTK6 | 0.37483498 |
| 77 | PRKCI | 0.36483817 |
| 78 | PRKAA2 | 0.35552252 |
| 79 | SIK1 | 0.34083604 |
| 80 | BMPR2 | 0.33892378 |
| 81 | PDPK1 | 0.30872936 |
| 82 | FGFR3 | 0.30011683 |
| 83 | MAP4K2 | 0.29962504 |
| 84 | PIM2 | 0.29866439 |
| 85 | PDGFRA | 0.29169079 |
| 86 | IRAK1 | 0.27984124 |
| 87 | LATS2 | 0.27710872 |
| 88 | EEF2K | 0.27520041 |
| 89 | PRKCE | 0.27016235 |
| 90 | STK3 | 0.25462676 |
| 91 | AKT2 | 0.22282375 |
| 92 | ITK | 0.22138384 |
| 93 | SRC | 0.22117202 |
| 94 | TGFBR1 | 0.22007627 |
| 95 | SIK3 | 0.21991488 |
| 96 | CAMK2D | 0.21554206 |
| 97 | BRSK2 | 0.20938730 |
| 98 | NTRK1 | 0.20258087 |
| 99 | CDK19 | 0.18533082 |
| 100 | ILK | 0.16866684 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.87460968 |
| 2 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 3.70574611 |
| 3 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.52544482 |
| 4 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 3.51529697 |
| 5 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 3.41614956 |
| 6 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 3.11756915 |
| 7 | Retinol metabolism_Homo sapiens_hsa00830 | 2.92692373 |
| 8 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.71942444 |
| 9 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.67900610 |
| 10 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.60503631 |
| 11 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.53461313 |
| 12 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.49378732 |
| 13 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.48855722 |
| 14 | Histidine metabolism_Homo sapiens_hsa00340 | 2.48470090 |
| 15 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.45470220 |
| 16 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.36290707 |
| 17 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.08697416 |
| 18 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.96810137 |
| 19 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.95782768 |
| 20 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.93906023 |
| 21 | Bile secretion_Homo sapiens_hsa04976 | 1.90534614 |
| 22 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.85867171 |
| 23 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.85852605 |
| 24 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.76264734 |
| 25 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.60885550 |
| 26 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.59587260 |
| 27 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.49889679 |
| 28 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.42195967 |
| 29 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.37364187 |
| 30 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.33216130 |
| 31 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.32493049 |
| 32 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.25130164 |
| 33 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.21995500 |
| 34 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.21848246 |
| 35 | Galactose metabolism_Homo sapiens_hsa00052 | 1.13948144 |
| 36 | Peroxisome_Homo sapiens_hsa04146 | 1.11243776 |
| 37 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.09315414 |
| 38 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.04844747 |
| 39 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.02525705 |
| 40 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.99591090 |
| 41 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.97865937 |
| 42 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.89754743 |
| 43 | Proteasome_Homo sapiens_hsa03050 | 0.89564934 |
| 44 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.88185835 |
| 45 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.87111877 |
| 46 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.81516072 |
| 47 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.75777666 |
| 48 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.74429521 |
| 49 | ABC transporters_Homo sapiens_hsa02010 | 0.72583050 |
| 50 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.71387322 |
| 51 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.70957635 |
| 52 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.69253906 |
| 53 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.69067729 |
| 54 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.68972522 |
| 55 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.68680873 |
| 56 | Mineral absorption_Homo sapiens_hsa04978 | 0.66541798 |
| 57 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.65115004 |
| 58 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.63948458 |
| 59 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.57227563 |
| 60 | Metabolic pathways_Homo sapiens_hsa01100 | 0.55619380 |
| 61 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.54640250 |
| 62 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.53508916 |
| 63 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.52894220 |
| 64 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.50893912 |
| 65 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.49778116 |
| 66 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.48810275 |
| 67 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.48354063 |
| 68 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.42686980 |
| 69 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.42473373 |
| 70 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.42406583 |
| 71 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.42283785 |
| 72 | Tight junction_Homo sapiens_hsa04530 | 0.40712779 |
| 73 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.36266107 |
| 74 | Carbon metabolism_Homo sapiens_hsa01200 | 0.35104473 |
| 75 | Adherens junction_Homo sapiens_hsa04520 | 0.33924192 |
| 76 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.33325886 |
| 77 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.30666450 |
| 78 | Huntingtons disease_Homo sapiens_hsa05016 | 0.29587360 |
| 79 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.28449626 |
| 80 | Sulfur relay system_Homo sapiens_hsa04122 | 0.26782902 |
| 81 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.26056081 |
| 82 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.22172396 |
| 83 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.20085000 |
| 84 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.18873102 |
| 85 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.18597203 |
| 86 | Insulin resistance_Homo sapiens_hsa04931 | 0.15767937 |
| 87 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.12039601 |
| 88 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.11923257 |
| 89 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.10567341 |
| 90 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.09669251 |
| 91 | Focal adhesion_Homo sapiens_hsa04510 | 0.09439216 |
| 92 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.06318134 |
| 93 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.06081773 |
| 94 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.04302019 |
| 95 | Amoebiasis_Homo sapiens_hsa05146 | 0.02799971 |
| 96 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.01688555 |
| 97 | Hepatitis C_Homo sapiens_hsa05160 | 0.01133648 |
| 98 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.00359494 |
| 99 | Prion diseases_Homo sapiens_hsa05020 | 0.00214627 |
| 100 | Other glycan degradation_Homo sapiens_hsa00511 | -0.0062892 |

